Short answer
Exelon (EXC) filed its Q3 2025 10-Q quarterly report on Nov 4, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $6.7B (up 9.0% year over year) with net income of $874M.
Q3 2025 key financials · XBRL
- Revenue
- $6.7B
- +9.0% YoY · +23.5% QoQ
- Net income
- $874M
- +23.6% YoY · +123.0% QoQ
- Operating margin
- 22.4%
- EPS (diluted)
- $0.86
- +21.1% YoY · +120.5% QoQ
Source: XBRL data from the Exelon (EXC) Q3 2025 10-Q on SEC EDGAR. USD.
Exelon Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Exelon ComEd Q3 revenue $2,275M, up $46M YoY; 9-month revenue $6,176M, down $227M YoY
- ComEd Q3 operating income margin 24.5% (558/2,275) vs 22.3% (498/2,229) YoY; net income $373M up $13M
- PECO Q3 revenue $1,180M, up $150M YoY; net income $250M up $133M; 9-month net income up $296M
- BGE Q3 revenue $1,209M, up $165M YoY; net income $82M up $37M; 9-month net income up $45M
- Increased interest expense across segments due to more debt; effective tax rate increased significantly YoY (e.g., ComEd 18.2% vs 9.1%)
- Management notes higher distribution/transmission rate base and regulatory returns supporting income gains; storm cost deferrals helped PECO
- Revenue increases driven mainly by distribution and regulatory required programs; electricity and gas volumes stable or slightly down due to customer load
- No update on overall company outlook or guidance; mentions impacts of regulatory changes (e.g., Next Generation Energy Act) and continuing capital investments
Risk Factors
- No new or updated risk factors disclosed in this 10-Q vs prior 10-K filing
- Carried-forward regulatory risk: compliance with SEC rules including Regulation S-K and Section 1350 Sarbanes-Oxley certifications
- Operational risk: potential impacts from contract instruments and agreements referenced under Rule 12b-32 for subsidiaries
- Financial risk: no material changes to debt or liquidity risks; Supplemental Indenture dated August 15, 2025 filed with trustee
- Corporate governance risk: no changes to Rule 10b5-1 trading arrangements for officers or directors in this quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Exelon quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.